Career Development Award

0 Saves · 0 Shares · 0 Comments Discussion

Grant Name

Funder

National Hemophilia Foundation (NHF)

Country or Region

United States

Research Field

Animal Genome

Animal Models

Blood Coagulation

Blood Diseases

Gene Therapy

Genetics

Gene Transfer

Hemophilia

Human Genome

Immunity & Immunogenetics

Immunology

Medical Treatment

Phenotype

Proteins and Macromolecules

Retrovirus

Virology

Deadline

February 8, 2022 (Expired)

Grant Size

Upper $210,000USD Lower $70,000USD NHF will award up to $70,000 annually for a maximum of three years.

Contact Info

Dr. Michelle Witkop, NHF Head of Research mwitkop@hemophilia.org

Eligibility

Career Development Award (CDA) candidates must hold a MD, PhD, or equivalent degree, with no more than six years of postdoctoral years of experience in hematology, nor more than six years since completion of medical training. United States citizenship is not required, but applicants must be affiliated with or be faculty members of a U.S.-based organization such as - universities, colleges, hospitals or laboratories. Only non-commercial institutions and investigators associated with a non-commercial institution are eligible to apply for this award.

Description

NHF seeks research grant applications from established investigators, preferably at the assistant professor level or above, who have demonstrated a commitment to bleeding disorders research. We especially encourage innovative projects that promote the development of novel technologies and/or therapies to advance the field of bleeding disorders research. NHF is interested in funding innovative research studies in bleeding disorders to be carried out at the sub cellular, cellular, animal or human/patient levels. While gene therapy has been an approach which has shown much promise in hemophilia, no one method has been demonstrated to be superior. Multiple experimental strategies may be undertaken to help find a “cure” for bleeding disorders. NHF is seeking research proposals on the nature, propagation, and use of hematopoietic, liver, or stem cells as an approach for gene transfer in hemophilia or for other novel approaches for treating bleeding disorders.NHF is interested in funding innovative research studies in bleeding disorders to be carried out at the sub cellular, cellular, animal or human/patient levels. Eligibility Career Development Award (CDA) candidates must hold a MD, PhD, or equivalent degree, with no more than six years of postdoctoral years of experience in hematology, nor more than six years since completion of medical training. United States citizenship is not required, but applicants must be affiliated with or be faculty members of a U.S.-based organization such as - universities, colleges, hospitals or laboratories. Only non-commercial institutions and investigators associated with a non-commercial institution are eligible to apply for this award.

Website

https://www.hemophilia.org/research/fund-your-research/career-development-award

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link